1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Europe Antibiotics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class ; Action Mechanism ; and Country

Europe Antibiotics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class ; Action Mechanism ; and Country

  • June 2020
  • 127 pages
  • ID: 5915415
  • Format: PDF
  • The Insight Partners


Table of Contents

Search Inside

The Europe antibiotics market is expected to reach US$ 15,569.87 million by 2027 from US$ 12,457.70 million in 2019. The market is estimated to grow with a CAGR of 3.1% from 2020 to 2027.
The antibiotics market is growing primarily due toprevalence of infectious diseases and increasing development of generic drugsin the Europe region that are boosting the market over the years.Restraining factors, such as tedious and expensive process of antibiotic development islikely to slow down the growth of the market in the coming years.

Additionally,growing investments to combat antimicrobial resistanceand incorporation of novel computing technologies for antibiotics discoveryare likely to increase the growth of the antibioticsmarket in the forecast period.
Antibiotics are medicines containing substances that are active against bacteria.These medicines either kill the bacteria or control the infection by inhibiting the bacterial reproduction, which in turn helps patient to recover.

Antibiotics are specific to the type of bacteria being treated and are not able to be interchanged from one infection to another.
Bacterial infection refers to the proliferation of harmful bacterial strains on or inside the human body.These microorganisms can infect any part of the body and may lead to severe consequences.

A few of the indications of bacterial infections include pneumonia, meningitis, and food poisoning. Moreover, several commonly occurring pediatric bacterial infections are acute otitis media (AOM), sinusitis, bronchitis, upper respiratory tract infection, and pharyngitis.
Generic versions are introduced in the market with an aim to offer cost-efficient drugs and increase the reach of these drugs to people belonging to different economic classes.Generic versions are popular due to their availability and affordability.

Additionally, the companies are focusing on development of generic versions to offer antibiotics at minimal costs.Also, pressure to control pharmaceutical expenditure and price competition among pharmaceutical companies are fueling the development of generic medicines markets in Europe.

Therefore, generic manufacturers with low production costs, broad portfolios, and stable supplies would witness a robust market growth. Thus, the above factors are likely to drive the growth of antibiotic market in the forecasted period.
Europe has been massively hit by COVID-19 outbreak affecting many of its countries on a large scale.Italy, Germany, Spain, the UK, and France along with other European countries are continually witnessing rise in number of COVID-19 cases every day.

In March 2020, European Medicines Agency has formed an executive committee to deal with impact of COVID-19 on supply chain of medicines.According to a data published in a newsletter in March 2020, majority of the European pharmaceutical companies has its manufacturing facilities located in India, while an estimated 70% of the raw ingredients comes from China.

This whole supply chain is likely to hamper due to industrial shutdowns, which will ultimately hamper the growth of the market.
In 2019, the cephalosporin segment accounted for the largest share of the market; it is further expected to continue its dominance duringthe forecast period.This class of antibiotics is usually safe due to low toxicity to self-cells and remarkable efficiency against susceptible bacteria.

On the other hand, fluoroquinolones are expected to register the highest CAGR in the antibiotics market during 2020-2027.
Some of the significant secondary sources for antibiotics market included in the report are the World Health Organization (WHO), European Medicines Agency (EMA),and others.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on